RxDoctor Payments Data

William Munn, PA

Physician Assistant · Rocky Mount, NCNPI 1053386078

Payments from drug & device makers

$798in general payments, 2019–2025

Across 50 payments — averaging $15.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$200
  • Lilly USA, LLC$149
  • Novo Nordisk$86
  • Pfizer$69
  • Esperion Therapeutics, Inc.$69
  • Merck$47
  • plus $177 from 7 others

What the payments were for

  • Food & beverage$798100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$798 in reported general payments places this provider in the 65th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$91,923
Medicare patients
248
Services billed
4,297

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban139$126,546
OzempicSemaglutide69$76,146
LinzessLinaclotide84$72,250
JanuviaSitagliptin Phosphate48$41,584
TrulicityDulaglutide33$39,729
JardianceEmpagliflozin18$33,640
Trelegy ElliptaFluticasone/Umeclidin/Vilanter43$29,367
TradjentaLinagliptin33$27,607
XareltoRivaroxaban22$24,359
Tresiba Flextouch U-200Insulin Degludec22$21,978
FarxigaDapagliflozin Propanediol18$21,520
EntrestoSacubitril/Valsartan13$18,765
Tresiba Flextouch U-100Insulin Degludec21$13,220
Atorvastatin Calcium780$8,443
Breo ElliptaFluticasone/Vilanterol12$8,307

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$69$126,546139 claims
Novo NordiskOzempic$86$76,14669 claims
AbbVieLinzess$200$72,25084 claims
Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat$16$66,76462 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$36$45,73468 claims
MerckJanuvia$47$41,58448 claims
Lilly USA, LLCTrulicity$149$39,72933 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Rocky Mount

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →